Patents for A61P 35 - Antineoplastic agents (221,099)
05/2011
05/04/2011CN102040588A Tyrosine kinase inhibitor and medicinal application thereof in treating malignant tumor
05/04/2011CN102040578A Method for preparing high purity tricin from bamboo leaves
05/04/2011CN102040570A Sulfo-taxane derivative and preparation method and application thereof
05/04/2011CN102038959A Application of let-7/miR-98 family in preparation of medicament for treating disease related to FAS (Fatty Acid Synthase) gene
05/04/2011CN102038958A Nano particle composition and application thereof
05/04/2011CN102038957A Efficient cell nucleus targeted medicine vector and application thereof to preparing antineoplastic medicines
05/04/2011CN102038956A Tumor nucleus target medicinal vector and application thereof in preparing anti-tumor medicament
05/04/2011CN102038954A Water-soluble matrix suitable for preparing retinoic acid water-soluble preparation
05/04/2011CN102038935A Application of Cucurmosin in preparation of medicaments for treating cervical cancer
05/04/2011CN102038934A Application of cucurmosin in preparation of drug for treating breast cancer
05/04/2011CN102038915A Traditional Chinese medicament for treating hysteromyoma and preparation method thereof
05/04/2011CN102038888A Anti-tumor medicament for promoting tumor cell senescence and preparation method thereof
05/04/2011CN102038883A Traditional Chinese medicine formulation for treating gastric cancer
05/04/2011CN102038843A Syrup for treating gastric ulcer and lymphoma and preparation method thereof
05/04/2011CN102038834A Traditional Chinese medicine preparation for preventing and treating cancers
05/04/2011CN102038813A Coconut palm leaf extract and preparation method and use thereof
05/04/2011CN102038793A Preparation method of soapberry saponin
05/04/2011CN102038770A Antineoplastic traditional Chinese medicine composition
05/04/2011CN102038755A Traditional Chinese medicine formulation for treating fibroid
05/04/2011CN102038731A Original herb of common sowthistle hard capsules
05/04/2011CN102038730A Patrinia scabiosaefolia primitive hard capsules
05/04/2011CN102038729A Application of wingedtooth laggera herb in preparation of medicaments for resisting tumor metastasis
05/04/2011CN102038703A New use of microRNA
05/04/2011CN102038690A Application of bufarenogin to preparing antitumor medicinal preparation
05/04/2011CN102038678A Application of dihydroartemisinin to preparation of tumor cell autophagy induction medicament
05/04/2011CN102038677A Brominated dihydroartemisinin compound double-releasing preparation
05/04/2011CN102038673A Application of hydroxyl benzopyrone compound for preparing medicament for treating leukemia
05/04/2011CN102038663A Carbazole sulfonamide antineoplastic agent capsules and preparation method
05/04/2011CN102038652A Melphalan multi-targeted drug carrying system, and preparation method and application thereof
05/04/2011CN102038650A G.japonicum mycelium polysaccharide refined substance freeze-dried powder injection and preparation method thereof
05/04/2011CN102038644A Lutein water-soluble powder and preparation process thereof
05/04/2011CN102038641A Preparation method of liposome medicine with outer layer modified by hydrophilic polymer
05/04/2011CN102038640A Liposome medicament containing cholesterol PEG modifier and preparation method thereof
05/04/2011CN102038636A Taxane medicine solution containing chelating agent and preparation method thereof
05/04/2011CN102038635A Taxane medicine solution containing pH value regulator and preparation method thereof
05/04/2011CN102038634A Cosolvent-containing taxane medicinal solution and preparation method thereof
05/04/2011CN102038632A Controlled release preparation for polydiacetylene lipoid anti-cancer medicaments and preparation method thereof
05/04/2011CN102038190A Application of ampelopsin to preparation of anti-mutagenic health-care foods and medicaments
05/04/2011CN101698083B Medicament for preventing and treating lung cancer and preparation method thereof
05/04/2011CN101642436B 5-fluorouracil slow-release oral medicine and preparation method thereof
05/04/2011CN101638655B Carcinoembryonic antigen positive cell targeted gene expression element CPE and application thereof
05/04/2011CN101601669B United medicine used for treating tumors
05/04/2011CN101601649B Ubenimex fat emulsion injection and preparation method thereof
05/04/2011CN101575311B Method for preparing epiphysin
05/04/2011CN101565402B Indeno isoquinolone compound and preparation method and medical application thereof
05/04/2011CN101560521B Constructing method of VA1-missing adenovirus vector for expressing small interfering RNA (siRNA)
05/04/2011CN101536986B Sodium alginate targeted sustained release microsphere vascular occlusive agent containing Sorafenib as well as preparation and application thereof
05/04/2011CN101525626B Expression vector containing IER5 gene, monoclonal cell line and application thereof
05/04/2011CN101519438B Cyclic peptide compound in Hsisha sponge and application thereof
05/04/2011CN101491531B Use of bufadienolides compound and bufadienolides salinization compound in preparing medicine for treating gynecological tumor
05/04/2011CN101486703B Flavone compound with antineoplastic activity, preparation thereof and uses thereof
05/04/2011CN101485841B Health-care granule containing astragalus and coix seed
05/04/2011CN101461944B Magnetic polyacrylic acid modified carbon nano-tube medicament carrier
05/04/2011CN101445509B Sugar spiro-heterocycle compound with anti-tumor activity and preparation method thereof
05/04/2011CN101392010B Shikonin carbohydrate derivatives and synthetic method and use thereof
05/04/2011CN101392007B Anti-tumor manganese complexes using mitochondria as target point and preparation and use thereof
05/04/2011CN101391098B Apitoxin liposome preparation and preparation method thereof
05/04/2011CN101367822B Novel dihydro arteannuin derivant, preparation method and uses as medicament
05/04/2011CN101347446B Medicament composition containing astragalus polysaccharide and ginseng bud saponin and uses thereof
05/04/2011CN101337980B Ruthenium complexes for restraining DNA from topologizing isomerase , preparation method and application thereof
05/04/2011CN101333242B New antineoplastic compounds of triterpenoid saponin
05/04/2011CN101314617B Novel snake venom polypeptide, preparation and application thereof
05/04/2011CN101293933B Polyglycol modified chitosan oligosaccharide fatty acid grafting article, preparing method and application thereof
05/04/2011CN101284834B Bi-inulicin 1, preparation method and applications thereof
05/04/2011CN101284820B Amino peptidase inhibiting substance and synthetic method
05/04/2011CN101269223B Anthracene nucleus medicament nano-preparation, preparation method and application thereof
05/04/2011CN101264279B Chinese medicinal composition for treating common cancer and producing method thereof
05/04/2011CN101253192B Antitumor agent
05/04/2011CN101225040B Method for extracting crocetin from gardenia
05/04/2011CN101155782B Potentiator for radiation therapy comprising pyridine derivative as active ingredient
05/04/2011CN101155600B Radiotherapy enhancer
05/04/2011CN101148475B Human breast cancer resisting recombination immunotoxin M4G3/ScFv-PE40
05/04/2011CN101125146B Medicine target for preventing and treating cardiovascular and cerebrovascular diseases associated with inflammation and its inhibitor
05/04/2011CN101104608B Solanesol derivative, preparation and application thereof
05/04/2011CN101103005B Quinazoline derivatives, preparation methods and uses thereof
05/04/2011CN101088555B Medicine preparation for inhibiting tumor angiogenesis and cancer cell and enhancing immunity
05/04/2011CN101066993B Recombinant staphylococcus aureus enterotoxin M and its preparation and application
05/04/2011CN101057913B New medical use of vitex and method for preparing medicinal intermediate
05/04/2011CN101032483B Hydantoin derivative for adjusting estrogen receptor activity and application thereof
05/04/2011CN101007052B An antitumor medicine and its preparation method
05/03/2011US7935786 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
05/03/2011US7935784 Immunoglobulin fusion which targets extracellullar domain of human estrogen receptor for use in diagnosis, prevention and treatment of cell proliferative disorders
05/03/2011US7935694 Lactam compounds useful as protein kinase inhibitors
05/03/2011US7935693 Polycyclic aryl substituted triazoles and polycyclic heteroaryl substituted triazoles useful as Axl inhibitors
05/03/2011US7935692 Polyamine compounds are used to mobilize and harvest CD34+ cells via apheresis with and without combinations with other mobilizing factors; bind to chemokine receptors; regeneration of heart tissue
05/03/2011US7935675 Immunostimulatory nucleic acid molecules
05/03/2011US7935346 Medicament for the two-step perioperative therapy of solid tumours
05/03/2011US7935343 Immunoglobulin specific to interleukin-13 (IL-13) for use in prevention and treatment of asthma, fibrosis, skin and cell proliferative disorders
05/03/2011CA2581001C Kunitz-type recombinant inhibitor
05/03/2011CA2557184C Pyrazolotriazines as kinase inhibitors
05/03/2011CA2489824C Processes for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinases
05/03/2011CA2484340C 2-(quinolonyl)-fused heterocycles as androgen receptor modulators
05/03/2011CA2473026C 2-(pyridin-2-ylamino)-pyrido[2,3-d]pyrimidin-7-ones
05/03/2011CA2469649C Derivatives of isoindigo, indigo and indirubin and use in treating cancer
05/03/2011CA2467517C Substituted benzoxazoles and analogues as estrogenic agents
05/03/2011CA2454048C Therapeutic agents comprising pro-apoptotic proteins
05/03/2011CA2443632C Timed pulse release composition
05/03/2011CA2440091C Prodrugs of anticancer agents employing substituted aromatic acids
05/03/2011CA2439709C Aryl and heteroaryl urea chki inhibitors for use as radiosensitizers and chemosensitizers
05/03/2011CA2438085C Pharmaceutical compositions containing fluorinated or perfluorinated carboxylic acids